Benefit from Chimera Biotec‘s 20 years of in-depth experience as the specialty CRO for immunoassays which go beyond the scope of what is usually considered feasible.

Understanding the critical role ultra sensitive bioanalysis in the development of novel therapeutics, Chimera Biotec is committed to providing support for all phases of the drug development process.

Make use of our services in:

  • Pre-clinics: Biomarker, PK, Immunogenicity, Microsampling
  • Phase I-IV: Biomarker, PK, Immunogenicity, Microsampling, Multi-Center Trial Support
  • Single PK-Assay throughout all phases; Pre-clinics to Phase IV

From "proof of concept" over ICH GCP to full GLP compliancy, all desired and required regulatory regimes are available.